Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: J Glaucoma. 2014 Oct-Nov;23(8):494–500. doi: 10.1097/IJG.0b013e318285fd95

Table 1.

Summary of patients’ characteristics

GS, n=42; mean (SD) EMG, n= 22; mean (SD)
IOP OD (mm Hg) 15.16 (3.53) 15.6 (3.24)
IOP OS (mm Hg) 15.92 (4.2) 15.4 (2.7)
Vertical C/D OD 0.53 (0.14) 0.56 (0.17)
Vertical C/D OS 0.53 (0.15) 0.56 (0.20)
CCT OD (μm) 542.17 (39.4) 530.80 (46.19)
CCT OS (μm) 541.93 (38.72) 529.70 (50.74)
MD OD (dB) −0.83 (1.82) −2.34 (2.47)
MD OS (dB) −0.96 (1.79) −1.90 (2.26)
Treatment PA, n=6;
BB, n=2
PA, n=11
BB, n=2
AA, n=1
BB+ PA, n=4
PA+ CAI, n=1
AA+CAI, n=1

Legend. PA, prostaglandin analogs; BB, beta-blockers; AA, alpha-agonists; CAI, carbonic anhydrase inhibitors